Contact
 

Vaccine Induced Sero-Positivity/Reactivity Presentations

14 March

length

Item

Lead/speaker

08:30 - 08:45

Welcome and logistics                                             

Mary Marovich

08:45 - 09:25

Vaccine Candidates Pipeline  

Barney Graham

09:25 - 10:05

 HIV Diagnostic Algorithms in the Clinic  

Sheila Peel

10:05 - 10:45

HVTN VISP/R Program  

Carissa Karg, John Hural

10:45 - 11:10

Current VISP/R Practices Overview 

Mary Allen

11:30-12:30

Best Practices Discussion  

Pat Fast

13:45 - 14:15

Pipeline Diagnostic Tests  

Mark Ware

14:15 - 14:45

Challenges in Developing and Commercializing HIV Tests that are Useful in Differentiating VISP  

Chris Bentsen

14:45 - 15:10

Developing a Commercial VISP Test: SELECTEST Experience  

Andrew Levin

 15:10 - 15:50 Molecular POC Diagnostics: SAMBA    Helen Lee

15:50 - 16:50

Roundatable Panel Discussion on Diagnostic Tests 

Bob Coombs, Helen Lee, Michele Owen, Marco Schito, Mark Ware

16:50 - 17:00

VISP/R Terminology -- Community Focus Groups Perspective 

Helene Zinszner

 

15 March 2013

08:40 - 10:00

Discussion Groups

  • Social Impact and informed Consent
  • Technical Feasibility at Trial and Public Health Levels
  • Financial Issues of Trial Follow up
  • Logistical Issues of Trial Follow up

 

 

  • Chair: Pat Fast
  • Chair: Michael Busch
  • Chair: Margaret McCluskey
  • Carissa Karg

10:00 - 11:00

Discussion Group Reports and General Discussion

Chairs/Rapporteurs

11:20 - 11:40

Preparing for Vaccine Licensure - US Perspective 

Hana Golding

11:40 - 12:00

Preparing for Vaccine Licensure - African Perspective 

Joseph Mulenga

12:00 - 12:30 Vaccine Licensure and VISP/R Discussion  Joseph Mulenga

12:30 - 12:50

Meeting Summary 

Bob Coombs

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account